Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Current Deferred Revenue (2016 - 2025)

Cellectis (CLLS) has 3 years of Current Deferred Revenue data on record, last reported at $59000.0 in Q4 2022.

  • For Q4 2022, Current Deferred Revenue changed N/A year-over-year to $59000.0; the TTM value through Dec 2022 reached $59000.0, changed N/A, while the annual FY2022 figure was $59000.0, N/A changed from the prior year.
  • Current Deferred Revenue reached $59000.0 in Q4 2022 per CLLS's latest filing, down from $26.1 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $59000.0 in Q4 2022 and bottomed at $59000.0 in Q4 2022.